Investigation Report on China's Insulin Aspart Market, 2018-2022

Publisher Name :
Date: 01-Nov-2018
No. of pages: 30

Description

The rapid development of the Chinese economy in the past three decades has changed people's dietary habits and reduced physical activities, which leads to an increasing incidence of obesity-related diseases. It is estimated that at the end of 2017, there were more than 100 million diabetic patients in China. The market size of diabetes drugs is also growing in China.

On Dec. 26, 2001, Novo Nordisk announced that Insulin Aspart (trade name: NovoRapid), the first and only insulin analog that can be used with insulin pumps, was approved by the FDA. Insulin Aspart starts working in 10 to 20 minutes after subcutaneous injection and can reduce postprandial blood glucose and glycated hemoglobin (HbA1c). On the basis of Insulin Aspart, Novo Nordisk developed premixed insulin aspart containing soluble insulin aspart and protaminated insulin aspart of various proportions. The combination of the fast-acting form and the long-acting form allows patients to receive fewer injections over the course of the day. NovoLog Mix 70/30, containing 30% soluble insulin aspart and 70% protaminated insulin aspart, was approved by the FDA in Nov. 2001. Similar NovoLog Mix 50/50 was approved by the FDA in Aug. 2008. In Apr. 2005, NovoMix 30 (30% soluble insulin aspart and 70% protaminated insulin aspart), the first premixed insulin analog, was launched in China. According to CRI, from 2005 to 2017, the sales value of Insulin Aspart in China grew by over 100 times. The market size of Insulin Aspart in China exceeded CNY 200 million in 2017.

Because there are high technical barriers against the imitation of Insulin Aspart, by Oct. 2018, China's Insulin Aspart market is monopolized by Novo Nordisk's Insulin Aspart (NovoRapid). According to CRI, several Chinese companies are applying for the CFDA's approval for generic Insulin Aspart. However, the launch of generic drugs will take several years. With an increasing number of diabetic patients, the market size of Insulin Aspart in China will maintain rapid growth in the next few years.

Topics Covered:


  • Situation of diabetes in China

  • Sales of Insulin Aspart in China

  • Prices of Insulin Aspart in China

  • Progress of generic Insulin Aspart in China

  • Prospect of China's Insulin Aspart market from 2018 to 2022

Investigation Report on China's Insulin Aspart Market, 2018-2022

Table of Contents

1 Relevant Concepts of Insulin Aspart
1.1 Indications for Insulin Aspart
1.2 Development of Insulin Aspart in China
1.3 Patents and Government Approval on Insulin Aspart in China

2 Sales of Insulin Aspart in China, 2013-2017
2.1 Sales Value of Insulin Aspart
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Insulin Aspart
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Insulin Aspart by Dosage Form in China, 2013-2017

3 Analysis on Major Insulin Aspart Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Insulin Aspart Manufacturers
3.2 Novo Nordisk
3.2.1 Enterprise Profile
3.2.2 Sales of Novo Nordisk's Insulin Aspart in China

4 Prices of Insulin Aspart in China, 2017-2018
4.1 Novo Nordisk (NovoRapid)
4.2 Progress of Generic Drugs

5 Prospect of China's Insulin Aspart Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

List of Charts

Chart Sales of Insulin Aspart in China, 2013-2017
Chart Sales Value of Insulin Aspart in Parts of China, 2013-2017
Chart Sales Volume of Insulin Aspart in China, 2013-2017
Chart Sales Volume of Insulin Aspart in Parts of China, 2013-2017
Chart Sales Value of Insulin Aspart Injections in China, 2013-2017
Chart Sales Volume of Insulin Aspart Injections in China, 2013-2017
Chart Sales Value of Novo Nordisk's Insulin Aspart (NovoRapid), 2013-2017
Chart Sales Volume of Novo Nordisk's Insulin Aspart (NovoRapid), 2013-2017
Chart Prices of Novo Nordisk's Insulin Aspart (NovoRapid) in Parts of China in 2017

  • 2014-2029 Report on Global Glucagon Market by Player, Region, Type, Application and Sales Channel
    Published: 31-Mar-2020        Price: US 2500 Onwards        Pages: 107
    The global Glucagon market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Glucagon from 2014-2019, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future persp......
  • Global Antidiabetic Biguanides Market Research Report 2020
    Published: 30-Mar-2020        Price: US 2900 Onwards        Pages: 120
    The global Antidiabetic Biguanides market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Antidiabetic Biguanides volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antidiabetic Biguanides market size by analysing historical data and future prospect. Regionally, this report focuses on se......
  • Global Antidiabetic Sulphonylureas Market Research Report 2020
    Published: 30-Mar-2020        Price: US 2900 Onwards        Pages: 116
    The global Antidiabetic Sulphonylureas market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Antidiabetic Sulphonylureas volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antidiabetic Sulphonylureas market size by analysing historical data and future prospect. Regionally, this report f......
  • Global Antidiabetic SGLT-2 Inhibitor Market Research Report 2020
    Published: 30-Mar-2020        Price: US 2900 Onwards        Pages: 117
    The global Antidiabetic SGLT-2 Inhibitor market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Antidiabetic SGLT-2 Inhibitor volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antidiabetic SGLT-2 Inhibitor market size by analysing historical data and future prospect. Regionally, this re......
  • Global Antidiabetic Thiazolidinediones Market Research Report 2020
    Published: 30-Mar-2020        Price: US 2900 Onwards        Pages: 98
    The global Antidiabetic Thiazolidinediones market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Antidiabetic Thiazolidinediones volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antidiabetic Thiazolidinediones market size by analysing historical data and future prospect. Regionally, t......
  • Global Acarbose Market Research Report 2020
    Published: 30-Mar-2020        Price: US 2900 Onwards        Pages: 124
    The global Acarbose market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Acarbose volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Acarbose market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Chi......
  • Global Human Insulin Market Research Report 2020
    Published: 30-Mar-2020        Price: US 2900 Onwards        Pages: 99
    The global Human Insulin market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Human Insulin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Human Insulin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North Ameri......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 93
    The global Glucagon like peptide-1 (GLP-1) agonists market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Glucagon like peptide-1 (GLP-1) agonists volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Glucagon like peptide-1 (GLP-1) agonists market size by analysing historical data and fut......
  • Global Repaglinide Market Research Report 2020
    Published: 23-Mar-2020        Price: US 2900 Onwards        Pages: 97
    The global Repaglinide market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Repaglinide volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Repaglinide market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Eu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs